Diagnostic dilemmas: Overlapping features of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy

Frontiers in Physiology

Volumn 3 MAY, Issue , 2012, Pages

  Hoogendijk, Mark G ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Brugada syndrome; Desmo some; Sodium channel; Structural heart disease; Sudden cardiac death

Indexed keywords

EID: 84866352361     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00144     Document Type: Review

References (83)

1. Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., Hershberger, R. E., Judge, D. P., Le Marec, H., McKenna, W. J., Schulze-Bahr, E., Semsarian, C., Towbin, J. A., Watkins, H., Wilde, A., Wolpert, C., and Zipes, D. P. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 8, 1308-1339.
2. Alings, M., Dekker, L. R. C., Sadee, A., and Wilde, A. A. M. (2001). Quini-dine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin. Electrophysiol. 24, 1420-1422.
3. Amin, A. S., Meregalli, P. G., Bardai, A., Wilde, A. A. M., and Tan, H. L. (2008). Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann. Intern. Med. 149, 216-218.
4. Antzelevitch, C., Brugada, P., Borggrefe, M., Brugada, J., Brugada, R., Cor-rado, D., Gussak, I., LeMarec, H., Nademanee, K., Pérez Riera, A. R., Shimizu, W., Schulze-Bahr, E., Tan, H., and Wilde, A. (2005). Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111, 659-670.
5. Antzelevitch, C., Pollevick, G. D., Cordeiro, J. M., Casis, O., Sanguinetti, M. C., Aizawa, Y., Guerchicoff, A., Pfeiffer, R., Oliva, A., Wollnik, B., Gelber, P., Bonaros, E. P. Jr., Burashnikov, E., Wu, Y., Sargent, J. D., Schickel, S., Oberheiden, R., Bhatia, A., Hsu, L. F., Haïssaguerre, M., Schimpf, R., Borggrefe, M., and Wolpert, C. (2007). Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115,442-449.
6. Barajas-Martínez, H., Hu, D., Ferrer, T., Onetti, C. G., Wu, Y., Burashnikov, E., Boyle, M., Surman, T., Urrutia, J., Veltmann, C., Schimpf, R., Borggrefe, M., Wolpert, C., Ibrahim, B. B., Sánchez-Chapula, J. A., Winters, S., Haïssaguerre, M., and Antzelevitch, C. (2012). Molecular genetic and functional association of Brugada and earlyrepolariza-tion syndromes with S422L missense mutation in KCNJ8. Heart Rhythm 9, 548-555.
7. Belhassen, B., Glick, A., and Viskin, S. (2004). Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110, 1731-1737.
8. Borrmann, C. M., Grund, C., Kuhn, C., Hofmann, I., Pieperhoff, S., and Franke,W.W. (2006). The area com-posita of adhering junctions connecting heart muscle cells of vertebrates. II. Colocalizations of desmo-somal and fascia adherens molecules in the intercalated disk. Eur. J. Cell Biol. 85,469-485.
9. Brito, M. R., Miranda, C. E., Rabelo, W., and Marino, R. L. (2010). Type 1 electrocardiographic Brugada pattern in a woman with Chagas disease: a case report. Europace 12, 1345-1346.
10. Brugada, J., and Brugada, P. (1997). Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J. Cardiovasc. Electrophysiol. 8, 325-331.
11. Brugada, P., and Brugada, J. (1992). Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 20, 1391-1396.
12. Burashnikov, E., Pfeiffer, R., Barajas-Martinez, H., Delpón, E., Hu, D., Desai, M., Borggrefe, M., Haïssa-guerre, M., Kanter, R., Pollevick, G. D., Guerchicoff, A., Laiño, R., Marieb, M., Nademanee, K., Nam, G. B., Robles, R., Schimpf, R., Sta-pleton, D. D., Viskin, S., Winters, S., Wolpert, C.,Zimmern, S., Veltmann, C., and Antzelevitch, C. (2010). Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 7, 1872-1882.
13. Case, M. T., Sibinski, L. J., and Steffen, G. R. (1984). Chronic oral toxic-ity and oncogenicity studies of fle-cainide, an antiarrhythmic, in rats and mice. Toxicol. Appl. Pharmacol. 73,232-242.
14. Catalano, O., Antonaci, S., Moro, G., Mussida, M., Frascaroli, M., Baldi, M., Cobelli, F., Baiardi, P., Nas-toli, J., Bloise, R., Monteforte, N., Napolitano, C., and Priori, S. G. (2009). Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur. Heart J. 30, 2241-2248.
15. Chen, Q., Kirsch, G. E., Zhang, D., Brugada, R., Brugada, J., Brugada, P., Potenza, D., Moya, A., Borggrefe, M., Breithardt, G., Ortiz-Lopez, R., Wang, Z., Antzelevitch, C., O'Brien, R. E., Schulze-Bahr, E., Keating, M. T., Towbin, J. A., and Wang, Q. (1998). Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392,293-296.
16. Chiale, P. A., Przybylski, J., Laiño, R. A., Halpern, M. S., Sánchez, R. A., Gabrieli, A., Elizari, M. V., and Rosenbaum, M. B. (1982). Electrocardiographic changes evoked by ajmaline in chronic Chagas' disease without manifest myocarditis. Am. J. Cardiol. 49, 14-20.
17. Coronel, R., Casini, S., Koopmann, T. T., Wilms-Schopman, F. J. G., Verk-erk, A. O., de Groot, J. R., Bhuiyan, Z., Bezzina, C. R., Veldkamp, M. W., Linnenbank, A. C., van der Wal, A. C., Tan, H. L., Brugada, P., Wilde, A. A. M., and de Bakker, J. M. T. (2005). Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophys-iological, genetic, histopathologic, and computational study. Circulation 112,2769-2777.
18. Corrado, D., Basso, C., Buja, G., Nava, A., Rossi, L., and Thiene, G. (2001). Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 103, 710-717.
19. Corrado, D., Nava, A., Buja, G., Martini, B., Fasoli, G., Oselladore, L., Turrini, P., and Thiene, G. (1996). Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J. Am. Coll. Cardiol. 27, 443-448.
20. Cox, M. G., Nelen, M. R., Wilde, A. A., Wiesfeld, A. C., Smagt, J. J., Loh, P., Cramer, M. J., Doeven-dans, P. A., Tintelen, J. P., de Bakker, J. M., and Hauer, R. N. (2008). Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria. J. Cardiovasc. Electro-physiol. 19,775-781.
21. Delmar, M., and McKenna, W. J. (2010). The cardiac desmosome and arrhythmogenic cardiomyopathies. Circ. Res. 107, 700-714.
22. Delpon, E., Cordeiro, J., Nunez, L., Thomsen, P., Guerchicoff, A., Pollevick, G., Wu, Y., Kanters, J., Larsen, C., Burashnikov, E., Christiansen, M., and Antzelevitch, C. (2009). Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ. Arrhythm. Electrophysiol. 1, 209-218.
23. Fabritz, L., Hoogendijk, M. G., Scicluna, B. P., van Amersfoorth, S. C. M., Fortmueller, L., Wolf, S., Laakmann, S., Kreienkamp, N., Piccini, I., Breithardt, G., Ruiz Noppinger, P., Witt, H., Ebnet, K., Wichter, T., Levkau, B., Franke, W W., Pieperhoff, S., de Bakker, J. M. T., Coronel, R., and Kirchhof, P. (2011). Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J. Am. Coll. Cardiol. 57, 740-750.
24. Franke, W. W., Borrmann, C. M., Grund, C., and Pieperhoff, S. (2006). The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immuno-electron microscopy of desmoso-mal proteins. Eur. J. Cell Biol. 85, 69-82.
25. Frustaci, A., Priori, S. G., Pieroni, M., Chimenti, C., Napolitano, C., Riv-olta, I., Sanna, T., Bellocci, F., and Russo, M. A. (2005). Cardiac his-tological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112,3680-3687.
26. Garcia-Gras, E., Lombardi, R., Gio-condo, M. J., Willerson, J. T., Schneider, M. D., Khoury, D. S., and Marian, A. J. (2006). Suppression of canonical Wnt/β-catenin signaling by nuclear plako-globin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.J. Clin. Invest. 116, 2012-2021.
27. Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., Lerman, B. B., Markowitz, S. M., Ellinor, P. T., MacRae, C. A., Peters, S., Grossmann, K. S., Michely, B., Sasse-Klaassen, S., Birchmeier, W., Dietz, R., Breithardt, G., Schulze-Bahr, E., and Thierfelder, L. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36, 1162-1164.
28. Gomes, J., Finlay, M., Ahmed, A. K., Ciaccio, E. J., Asimaki, A., Saffitz, J. E., Quarta, G., Nobles, M., Syrris, P., Chaubey, S., McKenna, W. J., Tinker, A., and Lambiase, P. D. (2012). Elec-trophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study. Eur. Heart J. doi: 10.1093/eurheartj/ehr472
29. Heuser, A., Plovie, E. R., Ellinor, P. T., Grossmann, K. S., Shin, J. T., Wichter, T., Basson, C. T., Lerman, B. B., Sasse-Klaassen, S., Thierfelder, L., MacRae, C. A., and Gerull, B (2006). Mutant desmocollin-2 causes arrhythmogenic right ven tricular cardiomyopathy. Am. J. Hum. Genet. 79,1081-1088.
30. Hoogendijk, M. G., Potse, M., Linnen-bank, A. C., Verkerk, A. O., den Ruijter, H. M., van Amersfoorth, S. C M., Klaver, E. C., Beekman, L., Bezzina, C. R., Postema, P. G., Tan, H. L., Reimer, A. G., van der Wal, A. C., ten Harkel, A. D. J., Dalinghaus, M., Vinet, A., Wilde, A. A. M., de Bakker, J. M. T., and Coronel, R. (2010a). Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch. Heart Rhythm 7, 238-248.
31. Hoogendijk, M. G., Opthof, T., Postema, P. G., Wilde, A. A. M., de Bakker, J. M. T., and Coronel, R. (2010b). The Brugada ECG pattern: a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome. Circ. Arrhythm. Electrophysiol. 3, 283-290.
32. Hoogendijk, M. G., Potse, M., Vinet, A., de Bakker, J. M. T., and Coronel, R. (2011). ST segment elevation by current-to-load mismatch: an experimental and computational study. Heart Rhythm 8, 111-118.
33. Hu, D., Barajas-Martinez, H., Burash-nikov, E., Springer, M., Wu, Y., Varro, A., Pfeiffer, R., Koopmann, T., Cordeiro, J., Guerchicoff, A., Polle-vick, G., and Antzelevitch, C. A. (2009). Mutation in the β3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ. Arrhythm. Electrophysiol. 2, 270-278.
34. Ikeda, T., Abe, A., Yusu, S., Nakamura, K., Ishiguro, H., Mera, H., Yotsukura, M., and Yoshino, H. (2006). The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. J. Cardiovasc. Electrophysiol. 17, 602-607.
35. Ikeda, T., Sakurada, H., Sakabe, K., Sakata, T., Takami, M., Tezuka, N., Nakae, T., Noro, M., Enjoji, Y., Tejima, T., Sugi, K., and Yam-aguchi, T. (2001). Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J. Am. Coll. Cardiol. 37, 1628-1634.
36. Kapplinger, J. D., Landstrom, A. P., Salisbury, B. A., Callis, T. E., Polle-vick, G. D., Tester, D. J., Cox, M. G., Bhuiyan, Z., Bikker, H., Wiesfeld, A. C. P., Hauer, R. N., van Tinte-len, J. P., Jongbloed, J. D., Calkins, H., Judge, D. P., Wilde, A. A., and Ackerman, M. J. (2011). Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J. Am. Coll. Cardiol. 57,2317-2327.
37. Kasanuki, H., Ohnishi, S., Ohtuka, M., Matsuda, N., Nirei, T., Iso-gai, R., Shoda, M., Toyoshima, Y., and Hosoda, S. (1997). Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 95, 2277-2285.
38. Kattygnarath, D., Maugenre, S., Ney-roud, N., Balse, E., Ichai, C., Den-joy, I., Dilanian, G., Martins, R. l. P., Fressart, V., Berthet, M., Schott, J. J., Leenhardt, A., Probst, V., Le Marec, H., Hainque, B., Coulombe, A., Hatem, S. P. N., and Guich-eney, P. (2011). MOG1: a new susceptibility gene for Brugada syndrome. Circ. Cardiovasc. Genet. 4, 261-268.
39. Kirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schafers, M., Zellerhoff, S., Paul, M., Athai, T., Hiller, K. H., Baba, H. A., Breithardt, G., Ruiz, P., Wichter, T., and Levkau, B. (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114, 1799-1806.
40. Koopmann, T. T., Beekman, L., Alders, M., Meregalli, P. G., Mannens, M. M. A. M., Moorman, A. F. M., Wilde, A. A. M., and Bezzina, C. R. (2007). Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohort. Heart Rhythm 4, 752-755.
41. Krittayaphong, R., Veerakul, G., Nade-manee, K., and Kangkagate, C. (2003). Heart rate variability in patients with Brugada syndrome in Thailand. Eur. Heart J. 24, 1771-1778.
42. Kurita, T., Shimizu, W., Inagaki, M., Suyama, K., Taguchi, A., Satomi, K., Aihara, N., Kamakura, S., Kobayashi, J., and Kosakai, Y (2002). The elec-trophysiologic mechanism of ST-segment elevation in Brugada syndrome. J. Am. Coll. Cardiol. 40, 330-334.
43. Letsas, K. P., Efremidis, M., Weber, R., Korantzopoulos, P., Protonotarios, N., Prappa, E., Kounas, S. P., Evageli-dou, E. N., Xydonas, S., Kalusche, D., Sideris, A., and Arentz, T. (2011). Epsilon-like waves and ventricular conduction abnormalities in subjects with type 1 ECG pattern of Brugada syndrome. Heart Rhythm 8, 874-878.
44. London, B., Michalec, M., Mehdi, H., Zhu, X., Kerchner, L., Sanyal, S., Viswanathan, P. C., Pfahnl, A. E., Shang, L. L., Madhusudanan, M., Baty, C. J., Lagana, S., Aleong, R., Gutmann, R., Ackerman, M. J., McNamara, D. M., Weiss, R., and Dudley, S. C. Jr. (2007). Mutation in glycerol-3-phosphate dehydroge-nase 1-likegene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 116,2260-2268.
45. Marcus, F. I., Fontaine, G. H., Guiraudon, G., Frank, R., Lau-renceau, J. L., Malergue, C., and Grosgogeat, Y. (1982). Right ventricular dysplasia: a report of 24 adult cases. Circulation 65, 384-398.
46. Marcus, F. I., McKenna, W J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., Fontaine, G., Gear, K., Hauer, R., Nava, A., Picard, M. H., Protonotarios, N., Saffitz, J. E., Sanborn, D. M. Y., Steinberg, J. S., Tandri, H., Thiene, G., Towbin, J. A., Tsatsopoulou, A., Wichter, T., and Zareba, W (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation 121, 1533-1541.
47. Martini, B., Cannas, S., and Nava, A. (2001). Brugada by any other name? Eur. Heart J. 22, 1835-1836.
48. Martini, B., Nava, A., Thiene, G., Buja, G. F., Canciani, B., Scognamiglio, R., Daliento, L., and La Volta, S. (1989). Ventricular fibrillation without apparent heart disease: description of six cases. Am. Heart J. 118, 1203-1209.
49. Matsuo, K., Kurita, T., Inagaki, M., Kakishita, M., Aihara, N., Shimizu, W., Taguchi, A., Suyama, K., Kamakura, S., and Shimomura, K. (1999). The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur. Heart J. 20, 465-470.
50. McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., Norman, M., Baboonian, C., Jeffery, S., and McKenna, W J. (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmo-plantar keratoderma and woolly hair (Naxos disease). Lancet 355, 2119-2124.
51. Miyazaki, T., Mitamura, H., Miyoshi, S., Soejima, K., Ogawa, S., and Aizawa, Y (1996). Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J. Am. Coll. Cardiol. 27, 1061-1070.
52. Mizumaki, K., Fujiki, A., Tsuneda, T., Sakabe, M., Nishida, K., Sugao, M., and Inoue, H. (2004). Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J. Cardiovasc. Electrophysiol. 15,667-673.
53. Nademanee, K., Veerakul, G., Chan-danamattha, P., Chaothawee, L., Ariyachaipanich, A., Jirasiriro-janakorn, K., Likittanasombat, K., Bhuripanyo, K., and Ngarmukos, T. (2011). Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 123, 1270-1279.
54. Nagase, S., Kusano, K. F., Morita, H., Fujimoto, Y., Kakishita, M., Naka-mura, K., Emori, T., Matsubara, H., and Ohe, T. (2002). Epicardial elec-trogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J. Am. Coll. Cardiol. 39, 1992-1995.
55. Nagase, S., Kusano, K. F., Morita, H., Nishii, N., Banba, K., Watanabe, A., Hiramatsu, S., Nakamura, K., Sakuragi, S., and Ohe, T. (2008). Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. J. Am. Coll. Cardiol. 51, 1154-1161.
56. Nasir, K., Bomma, C., Tandri, H., Roguin, A., Dalal, D., Prakasa, K., Tichnell, C., James, C., Jspevak, P., Marcus, F., and Calkins, H. (2004). Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity. Circulation 110,1527-1534.
57. Ohkubo, K., Watanabe, I., Okumura, Y., Takagi, Y., Ashino, S., Kofune, M., Sugimura, H., Nakai, T., Kasamaki, Y., Hirayama, A., and Morimoto, S. I. (2010). Right ventricular his-tological substrate and conduction delay in patients with Brugada syndrome. Int. Heart J. 51, 17-23.
58. Oxford, E. M., Musa, H., Maass, K., Coombs, W., Taffet, S. M., and Delmar, M. (2007). Con-nexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ. Res. 101, 703-711.
59. Papavassiliu, T., Veltmann, C., Doesch, C., Haghi, D., Germans, T., Schoen-berg, S. O., van Rossum, A. C., Schimpf, R., Brade, J., Wolpert, C., and Borggrefe, M. (2010). Spontaneous type 1 electrocar-diographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome. Heart Rhythm 7, 1790-1796.
60. Papavassiliu, T., Wolpert, C., Fluchter, S., Schimpf, R., Neff, W., Haase, K. K., Duber, C., and Borggrefe, M. (2004). Magnetic resonance imaging findings in patients with Brugada syndrome. J. Cardiovasc. Electrophysiol. 15, 1133-1138.
61. Pérez Riera, A. R., Antzelevitch, C., Schapacknik, E., Dubner, S., and Ferreira, C. (2005). Is there an overlap between Brugada syndrome and arrhythmogenic right ventric ular cardiomyopathy/dysplasia? J Electrocardiol 38, 260-263.
62. Peters, S. (2008). Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: clues from long-term follow-up. Europace 10, 816-820.
63. Peters, S., Trummel, M., Denecke, S., and Koehler, B. (2004). Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy. Int. J. Cardiol. 95,207-210.
64. Pilichou, K., Nava, A., Basso, C., Beffagna, G., Bauce, B., Lorenzon, A., Frigo, G., Vettori, A., Valente, M., Towbin, J., Thiene, G., Danieli, G. A., andRampazzo,A. (2006). Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113, 1171-1179.
65. Pilichou, K., Remme, C. A., Basso, C., Campian, M. E., Rizzo, S., Bar-nett, P., Scicluna, B. P., Bauce, B., van den Hoff, M. J. B., de Bakker, J. M. T., Tan, H. L., Valente, M., Nava, A., Wilde, A. A. M., Moorman, A. F. M., Thiene, G., and Bezzina, C. R. (2009). Myocyte necrosis underlies progressive myocar-dial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J. Exp. Med. 206, 1787-1802.
66. Postema, P. G., van Dessel, P. E H. M., Kors, J. A., Linnenbank, A. C., van Herpen, G., Ritsema van Eck, H. J., van Geloven, N., de Bakker, J. M. T., Wilde, A. A. M., and Tan, H. L. (2010). Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in Brugada syndrome: a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation. J. Am. Coll. Cardiol. 55, 789-797.
67. Postema, P. G., Wolpert, C., Amin, A. S., Probst, V., Borggrefe, M., Roden, D. M., Priori, S. G., Tan, H. L., Hiraoka, M., Brugada, J., and Wilde, A. A. M. (2009). Drugs and Brugada syndrome patients: review of the literature, recom mendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 6, 1335-1341.
68. Probst, V., Veltmann, C., Eckardt, L., Meregalli, P. G., Gaita, F., Tan, H. L., Babuty, D., Sacher, F., Giustetto, C., Schulze-Bahr, E., Borggrefe, M., Haïssaguerre, M., Mabo, P., Le Marec, H., Wolpert, C., and Wilde, A. A. M. (2010). Long-term prognosis of patients diagnosed with Brugada syndrome. Circulation 121, 635-643.
69. Probst, V., Wilde, A. A. M., Barc, J., Sacher, F., Babuty, D., Mabo, P., Man-sourati, J., Le Scouarnec, S., Kyndt, F., Le Caignec, C., Guicheney, P., Gouas, L., Albuisson, J., Meregalli, P. G., Le Marec, H., Tan, H. L., and Schott, J. J. (2009). SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ. Cardiovasc. Genet. 2, 552-557.
70. Rampazzo, A., Nava, A., Malacrida, S., Beffagna, G., Bauce, B., Rossi, V., Zimbello, R., Simionati, B., Basso, C., Thiene, G., Towbin, J. A., and Danieli, G. A. (2002). Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 71, 1200-1206.
71. Royer, A., van Veen, T. A. B., Le Bouter, S., Marionneau, C., Griol-Charhbili, V., Leoni, A. L., Steenman, M., van Rijen, H. V M., Demolombe, S., Goddard, C. A., Richer, C., Escou-bet, B., Jarry-Guichard, T., Colledge, W H., Gros, D., de Bakker, J. M. T., Grace, A. A., Escande, D., and Charpentier, E (2005). Mouse model of SCN5A-linked hereditary Lene-gre's disease: age-related conduction slowing and myocardial fibrosis. Circulation 111, 1738-1746.
72. Santos, L. F., Rodrigues, B., Mor-eira, D., Correia, E., Nunes, L., Costa, A., Elvas, L., Pereira, T., Machado, J. C., Castedo, S., Hen-riques, C., Matos, A., and Santos, J. O. (2012). Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome. Europace. doi:10.1093/europace/eur421
73. Sato, P. Y., Musa, H., Coombs, W., Guerrero-Serna, G., Patino, G. A., Taffet, S. M., Isom, L. L., and Del-mar, M. (2009). Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ. Res. 105, 523-526.
74. Sen-Chowdhry, S., Syrris, P., and McKenna, W J. (2007a). Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 50,1813-1821.
75. Sen-Chowdhry, S., Syrris, P., Ward, D., Asimaki, A., Sevdalis, E., and McKenna, W.J. (2007b). Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115, 1710-1720.
76. Shimizu, W., Aiba, T., Kurita, T., and Kamakura, S. (2001). Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation.J. Cardiovasc. Electrophysiol. 12, 1418-1421.
77. Tada, H., Aihara, N., Ohe, T., Yutani, C., Hamada, S., Miyanuma, H., Takamiya, M., and Kamakura, S. (1998). Arrhythmogenic right ventricular cardiomyopathy underlies syndrome of right bundle branch block, ST-segment elevation, and sudden death. Am. J. Cardiol. 81, 519-522.
78. Takigawa, M., Noda, T., Shimizu, W., Miyamoto, K., Okamura, H., Satomi, K., Suyama, K., Aihara, N., Kamakura, S., and Kurita, T. (2008). Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm 5, 1523-1527.
79. Tanaka, H., Kinoshita, O., Uchikawa, S., Kasai, H., Nakamura, M., Izawa, A., Yokoseki, O., Kitabayashi, H., Takahashi, W., Yazaki, Y., Watanabe, N., Imamura, H., and Kubo, K. (2001). Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin. Electrophysiol. 24, 1293-1294.
80. Viskin, S., and Belhassen, B. (1995). When you only live twice. N. Engl. J.Med. 332, 1221-1225.
81. Watanabe, H., Koopmann, T. T., Le Scouarnec, S., Yang, T., Ingram, C. R., Schott, J., Demolombe, S., Probst, V., Anselme, F., Escande, D., Wiesfeld, A., Pfeurer, A., Kaab, S., Wichmann, H., Hasdemir, C., Aizawa, Y., Wilde, A. A. M., Roden, D., and Bezzina, C. (2008). Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 118,2260-2268.
82. Yan, G. X., and Antzelevitch, C. (1999). Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100, 1660-1666.
83. Zumhagen, S., Spieker, T., Rolinck, c J., Baba, H. A., Breithardt, G., Bocker, W., Eckardt, L., Paul, M., Wichter, T., and Schulze-Bahr, c E. (2009). Absence of pathog-nomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome. Circ. Arrhythm. Electrophysiol. 2, 16-23.